Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 524

1.

Thyroid Ultrasound-Guided Fine-Needle Aspiration Cytology Results: Observed Increase in Indeterminate Rate over the Past Decade.

Manning AM, Yang H, Falciglia M, Mark JR, Steward DL.

Otolaryngol Head Neck Surg. 2017 Apr;156(4):611-615. doi: 10.1177/0194599816688190. Epub 2017 Jan 24.

PMID:
28118554
2.

Risk Stratification of Thyroid Nodules With Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance (AUS/FLUS) Cytology Using Ultrasonography Patterns Defined by the 2015 ATA Guidelines.

Lee JH, Han K, Kim EK, Moon HJ, Yoon JH, Park VY, Kwak JY.

Ann Otol Rhinol Laryngol. 2017 Sep;126(9):625-633. doi: 10.1177/0003489417719472. Epub 2017 Jul 18.

PMID:
28719972
3.
4.

Low Malignancy Rates in Fine-Needle Aspiration Cytologies in a Primary Care Setting in Germany.

Eszlinger M, Ullmann M, Ruschenburg I, Böhme K, Görke F, Franzius C, Adam S, Molwitz T, Landvogt C, Amro B, Hach A, Feldmann B, Graf D, Wefer A, Niemann R, Bullmann C, Klaushenke G, Santen R, Tönshoff G, Ivancevic V, Kögler A, Bell E, Lorenz B, Kluge G, Hartenstein C, Paschke R.

Thyroid. 2017 Nov;27(11):1385-1392. doi: 10.1089/thy.2017.0167.

PMID:
28982301
5.

Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS).

Ho AS, Sarti EE, Jain KS, Wang H, Nixon IJ, Shaha AR, Shah JP, Kraus DH, Ghossein R, Fish SA, Wong RJ, Lin O, Morris LG.

Thyroid. 2014 May;24(5):832-9. doi: 10.1089/thy.2013.0317. Epub 2014 Mar 10.

6.
7.

Bethesda Category III, IV, and V Thyroid Nodules: Can Nodule Size Help Predict Malignancy?

Kiernan CM, Solórzano CC.

J Am Coll Surg. 2017 Jul;225(1):77-82. doi: 10.1016/j.jamcollsurg.2017.02.002. Epub 2017 Feb 20.

PMID:
28223197
8.

Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology.

Dincer N, Balci S, Yazgan A, Guney G, Ersoy R, Cakir B, Guler G.

Cytopathology. 2013 Dec;24(6):385-90. doi: 10.1111/cyt.12021. Epub 2012 Oct 18. Review.

PMID:
23078633
9.

Examining the Bethesda criteria risk stratification of thyroid nodules.

Deniwar A, Hambleton C, Thethi T, Moroz K, Kandil E.

Pathol Res Pract. 2015 May;211(5):345-8. doi: 10.1016/j.prp.2015.02.005. Epub 2015 Feb 27.

PMID:
25796296
10.

Reproducibility of atypia of undetermined significance/follicular lesion of undetermined significance category using the bethesda system for reporting thyroid cytology when reviewing slides from different institutions: A study of interobserver variability among cytopathologists.

Padmanabhan V, Marshall CB, Akdas Barkan G, Ghofrani M, Laser A, Tolgay Ocal I, David Sturgis C, Souers R, Kurtycz DF.

Diagn Cytopathol. 2017 May;45(5):399-405. doi: 10.1002/dc.23681. Epub 2017 Feb 20.

PMID:
28217980
11.

Hürthle cell presence alters the distribution and outcome of categories in the Bethesda system for reporting thyroid cytopathology.

Yazgan A, Balci S, Dincer N, Kiyak G, Tuzun D, Ersoy R, Cakir B, Guler G.

Cytopathology. 2014 Jun;25(3):185-9. doi: 10.1111/cyt.12093. Epub 2013 Sep 11.

PMID:
24024935
12.

Validation of American Thyroid Association Ultrasound Risk Assessment of Thyroid Nodules Selected for Ultrasound Fine-Needle Aspiration.

Tang AL, Falciglia M, Yang H, Mark JR, Steward DL.

Thyroid. 2017 Aug;27(8):1077-1082. doi: 10.1089/thy.2016.0555. Epub 2017 Jul 18.

PMID:
28657511
13.

Implications of a suspicious afirma test result in thyroid fine-needle aspiration cytology: an institutional experience.

Lastra RR, Pramick MR, Crammer CJ, LiVolsi VA, Baloch ZW.

Cancer Cytopathol. 2014 Oct;122(10):737-44. doi: 10.1002/cncy.21455. Epub 2014 Aug 13.

14.

The 5-tiered categorization system for reporting cytology is sufficient for management of patients with thyroid nodules compared to the 6-tiered Bethesda system.

Koh J, Moon HJ, Kim EK, Kwak JY, Yoon JH.

Endocrine. 2016 Aug;53(2):489-96. doi: 10.1007/s12020-015-0854-9. Epub 2016 Jan 12.

PMID:
26758996
15.

Risk of Malignancy and Risk of Neoplasia in the Bethesda Indeterminate Categories: Study on 4,532 Thyroid Fine-Needle Aspirations from a Single Institution in India.

Mahajan S, Srinivasan R, Rajwanshi A, Radotra B, Panda N, Dey P, Gupta N, Nijhawan R.

Acta Cytol. 2017;61(2):103-110. doi: 10.1159/000470825. Epub 2017 Apr 14.

PMID:
28407624
16.

The use of the Bethesda terminology in thyroid fine-needle aspiration results in a lower rate of surgery for nonmalignant nodules: a report from a reference center in Turkey.

Ozluk Y, Pehlivan E, Gulluoglu MG, Poyanli A, Salmaslioglu A, Colak N, Kapran Y, Yilmazbayhan D.

Int J Surg Pathol. 2011 Dec;19(6):761-71. doi: 10.1177/1066896911415667. Epub 2011 Jul 26.

PMID:
21791482
17.

The impact of atypia/follicular lesion of undetermined significance and repeat fine-needle aspiration: 5 years before and after implementation of the Bethesda System.

Sullivan PS, Hirschowitz SL, Fung PC, Apple SK.

Cancer Cytopathol. 2014 Dec;122(12):866-72. doi: 10.1002/cncy.21468. Epub 2014 Jul 30.

18.

Impact of the modification of the diagnostic criteria in the 2017 Bethesda System for Reporting Thyroid Cytopathology: a report of a single institution in Japan.

Higuchi M, Hirokawa M, Kanematsu R, Tanaka A, Suzuki A, Yamao N, Hayashi T, Kuma S, Miyauchi A.

Endocr J. 2018 Dec 28;65(12):1193-1198. doi: 10.1507/endocrj.EJ18-0290. Epub 2018 Oct 3.

19.

A histological assessment of the Bethesda system for reporting thyroid cytopathology (2010) abnormal categories: a series of 219 consecutive cases.

Tepeoğlu M, Bilezikçi B, Bayraktar SG.

Cytopathology. 2014 Feb;25(1):39-44. doi: 10.1111/cyt.12051. Epub 2013 Feb 26.

PMID:
23438201
20.

Supplemental Content

Support Center